Meridian Bioscience, Inc. (VIVO)
| Market Cap | 805.08M |
| Revenue (ttm) | 305.85M |
| Net Income (ttm) | 71.24M |
| Shares Out | 43.33M |
| EPS (ttm) | 1.62 |
| PE Ratio | 11.45 |
| Forward PE | 16.23 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 150,760 |
| Open | 18.40 |
| Previous Close | 18.45 |
| Day's Range | 18.20 - 18.68 |
| 52-Week Range | 15.45 - 30.65 |
| Beta | 0.49 |
| Analysts | Buy |
| Price Target | 26.00 (+39.8%) |
| Est. Earnings Date | Nov 12, 2021 |
About VIVO
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, including real-time PCR amplification under the Revogene brand; isothermal DNA amplification under the Alethia brand; lateral flow immunoassay using fluorescent chemistry under the Curian brand; rapid im...
Financial Performance
In 2020, VIVO's revenue was $253.67 million, an increase of 26.19% compared to the previous year's $201.01 million. Earnings were $46.19 million, an increase of 89.43%.
Financial StatementsAnalyst Forecast
According to 4 analysts, the average rating for VIVO stock is "Buy." The 12-month stock price forecast is 26.00, which is an increase of 39.78% from the latest price.
News
Meridian Bioscience to Hold Fourth Quarter and Full Year 2021 Financial Results Conference Call on November 12, 2021
CINCINNATI, Oct. 14, 2021 /PRNewswire/ -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a leading global provider of diagnostic testing solutions and life science raw materials, will report fourth quarter a...
Meridian Launches New Air-Dryable™ qPCR Mix Enabling Direct Detection of RNA from Whole Blood Samples
CINCINNATI, Oct. 7, 2021 /PRNewswire/ -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a leading global provider of diagnostic testing solutions and life science raw materials, announced today the launch of...
Meridian Launches Two New Air-Dryable qPCR Mixes Enabling Direct Detection of DNA or RNA from Stool Samples
CINCINNATI, Sept. 09, 2021 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc., a leading global provider of diagnostic testing solutions and life science raw materials, announced today the addition of two ne...
Meridian Launches Two New Air-Dryable qPCR Mixes Enabling Direct Detection of DNA or RNA from Saliva Samples
CINCINNATI, Sept. 07, 2021 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc., a leading global provider of diagnostic testing solutions and life science raw materials, announced today the launch of its new ...
Meridian Bioscience Expands Voluntary Recall of LeadCare Test Kits
Meridian Bioscience Inc's (NASDAQ: VIVO) subsidiary Magellan Diagnostics Inc has expanded the Class I recall of its LeadCare Test Kits used to detect lead in whole blood. Magellan provides two controls ...
Meridian Bioscience, Inc.: Magellan Diagnostics, Inc. Expands Voluntary Recall of LeadCare Test Kits
CINCINNATI, OH / ACCESSWIRE / September 1, 2021 / Meridian Bioscience, Inc. (NASDAQ:VIVO), a provider of diagnostic testing solutions and life science raw materials, today announced its wholly owned sub...
Got $1,000? These 2 Bargain-Bin Biopharma Stocks Might Be Worth Buying
These healthcare stocks have their warts, but the price is right for long-term investors.
Meridian Bioscience (VIVO) Q3 Earnings and Revenues Miss Estimates
Meridian Bioscience (VIVO) delivered earnings and revenue surprises of -29.03% and -13.15%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Meridian Bioscience: Q3 Earnings Insights
Shares of Meridian Bioscience (NASDAQ:VIVO) remained unaffected after the company reported Q3 results. Quarterly Results Earnings per share decreased 60.00% year over year to $0.22, which missed the est...
Meridian Bioscience Reports Third Quarter Fiscal 2021 Results
CINCINNATI, Aug. 06, 2021 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO) today announced financial results for the third quarter ended June 30, 2021.
4 Profitable Stocks to Boost Returns Using Net Income Ratio
DAC, BYD, CMRE, VIVO, and MGY qualified the screen for the net income ratio for the day.
Meridian Closes Acquisition of BreathTek® Business
CINCINNATI, Aug. 02, 2021 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc., a leading global provider of diagnostic testing solutions and life science raw materials, announced today that it closed the prev...
Analysts Estimate Meridian Bioscience (VIVO) to Report a Decline in Earnings: What to Look Out for
Meridian Bioscience (VIVO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Meridian Signs Definitive Agreement to Acquire Urea Breath Test for H. pylori from Otsuka America Pharmaceutical, Inc.
CINCINNATI, July 23, 2021 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc., a leading global provider of diagnostic testing solutions and life science raw materials, announced today that it signed a defini...
Meridian Bioscience to Hold Third Quarter Fiscal 2021 Financial Results Conference Call on August 6, 2021
CINCINNATI, July 14, 2021 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a provider of diagnostic testing solutions and life science raw materials, will report third quarter fiscal 2021 f...
Meridian Bioscience (VIVO) Outpaces Stock Market Gains: What You Should Know
In the latest trading session, Meridian Bioscience (VIVO) closed at $22.05, marking a +1.61% move from the previous day.
Meridian Resubmits Application to FDA for Emergency Use Authorization for Revogene® SARS-CoV-2 Molecular Assay
CINCINNATI, June 28, 2021 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc., a leading global provider of diagnostic testing solutions and life science raw materials, announced today that it has re-submitte...
Meridian's New Master Mix for LAMP Assays Offers a Practical Solution for POC Molecular Detection of RNA viruses
CINCINNATI, June 16, 2021 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc., a leading global provider of diagnostic testing solutions and life science raw materials, announced today the launch of the Lyo-R...
Meridian Bioscience to Participate in the 41st Annual William Blair Growth Stock Conference and Jefferies Virtual Hea...
CINCINNATI, May 27, 2021 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO) announced today participation in two upcoming investor conferences. Jack Kenny, Chief Executive Officer, will partic...
Meridian Improves Field-Testing in AgBio with its New Air-Dryable™ qPCR Mix for Crude Plant Samples
CINCINNATI, May 17, 2021 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc., a leading global provider of diagnostic testing solutions and life science raw materials, announced today the launch of its new Ai...
Meridian Bioscience (VIVO) Beats Q2 Earnings Estimates
Meridian Bioscience (VIVO) delivered earnings and revenue surprises of 16.67% and -2.26%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
Meridian Bioscience Reports Strong Growth in Net Revenues and EPS in Second Quarter Fiscal 2021
CINCINNATI, May 07, 2021 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO) today announced financial results for the second quarter ended March 31, 2021.
Meridian Bioscience (VIVO) Reports Next Week: Wall Street Expects Earnings Growth
Meridian Bioscience (VIVO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Meridian Bioscience (VIVO) Dips More Than Broader Markets: What You Should Know
Meridian Bioscience (VIVO) closed at $20.76 in the latest trading session, marking a -1.66% move from the prior day.
Meridian Simplifies Workflows for POC Molecular Tests with a New Lyo-Ready™ LAMP Mix
CINCINNATI, April 28, 2021 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc., a leading global provider of diagnostic testing solutions and life science raw materials, announced today the launch of the Lyo-...